Table 2. Gene Ontology analysis of the 201 nc886-regulated genes.
| GO | p-value | Genes |
|---|---|---|
| Regeneration | 0.006 | INA, CDKN1A, CCL2, MAP1B, VCAN |
| Regulation of transforming growth factor beta receptor signaling pathway | 0.007 | CDKN1C, HTRA1, HIPK2, C5ORF13 |
| Localization within membrane | 0.010 | EGFR, RAC1, MAL |
| Cellular response to stress | 0.014 | DBNL, CCM2, NUDT1, MAP1B, PMS2L4, RPA3, CDKN1A, EYA2, MAP1LC3A, POLD2, INSIG1, HIPK2, VACN |
| Cytoskeleton organization | 0.015 | ABLIM1, INA, LIMA1, STMN3, TMSB15A, MAP1B, RAC1, RALA, ANLN, CNN1, KRT86 |
| Cell death | 0.016 | GGCT, AIMP2, HSPBL2, GARS, TBRG4, RNF216, OPTN, TAX1BP1, DDIT4, EYA2, F3, HIPK2, RAC1, TGM2, SRGN |
| Regulation of cyclin-dependent protein kinase activity | 0.018 | EGFR, CDKN1C, CDKN1A, CDKN2C |
| Negative regulation of BMP signaling pathway | 0.019 | BMPER, HTRA1, HIPK2 |
| Interphase of mitotic cell cycle | 0.022 | EGFR, CDKN1C, CDKN1A, CDKN2C, TBRG4 |
| Negative regulation of apoptosis | 0.030 | EGFR, CDKN1A, CCL2, SFRP1, F3, HIPK2, HSPBL2, TGM2, TAX1BP1 |
| Vascularture development | 0.045 | CCM2, PDPN, CTGF, EFNB2, TGM2, SOX18, COL5A1 |
| Response to wounding | 0.047 | INA, CCL2, PDPN, CTGF, F3, MAP1B, RAC1, VCAN, AFAP1L2, CTSB, COL5A |
| Regulation of cell growth | 0.050 | CDKN1A, CDKN2C, CTGF, HTRA1, MAP1B, NPPB |
Significantly (p<0.05) enriched GO terms and names of individual genes therein